TC, as I read your last message, your premise is that the process is slowed because GNBT is not telling the public what they have found so far. I believe that to be an incorrect premise. The Malaysian deal (done) and the China deal (likely) indicates they are moving along with the research and the development of the combinations; telling the public what they have found so far does nothing to speed up the actual development of the vaccine.
As to the rest of the world, 1) if somebody comes calling, they can sign the same type of confidentiality agreement BK and China have likely signed or 2) if they don't come calling and GNBT develops a peptide vaccine that does well in trials, they WILL come calling. Don't see how either of those options are better served (or sped up) by releasing internal technological information that is proprietary to GNBT/NGIO.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links